Solara Active Pharma Sciences Reports Strong Q3 FY24-25 Financial Results and Improved Metrics

Solara Active Pharma Sciences has recently announced its financial results for the third quarter of FY24-25, with the report released on January 24, 2025. The company has experienced an adjustment in its evaluation, reflecting notable changes in its operational metrics.
The financial results for December 2024 highlight a significant enhancement in the operating profit to interest ratio, which now stands at 2.17 times. This marks the highest level observed in the last five quarters, suggesting a strengthened capacity for managing interest obligations.

In terms of profitability, Solara Active reported a profit before tax (PBT) of Rs 6.60 crore, showcasing a remarkable growth compared to the average PBT of Rs -66.38 crore from the preceding four quarters. The profit after tax (PAT) also reached a record high of Rs 8.09 crore, continuing its upward trajectory over the last five quarters.

Moreover, the company's inventory turnover ratio has improved to 4.34 times, the highest recorded in the last ten half-yearly periods. This indicates effective inventory management and robust sales performance.

For further insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.